Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gene Expression of Interferon (INF) and B Lymphocyte Biomarkers as Markers of Systemic Affectation and Lymphoproliferative Disease in Primary Sjögren's Syndrome

NCT03765593 is registered in ClinicalTrials.gov with National Council of Scientific and Technical Research, Argentina as lead sponsor.

NCT NCT03765593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03765593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gene Expression of Interferon (INF) and B Lymphocyte Biomarkers as Markers of Systemic Affectation and Lymphoproliferative Disease in Primary Sjögren's Syndrome
Lead sponsor
National Council of Scientific and Technical Research, Argentina
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2019
Completion date
March 31, 2021
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, non-hodgkin, primary sjögren syndrome